typing on the computer about my status
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Okay bud, thanks for the input.... You also said you cant short penny stocks.....
http://www.investopedia.com/ask/answers/06/otcpinksheetshortselling.asp
LOL that's really not that bad, I've seen 50-60 million or so, probably more, being accumulated by the market makers already in the past 3 months.
I'm sure they want to get rid of them at a much, much, much higher price.
I agree, the news that was released where just to get SNDY's awareness up. The MM's have been accumulating between .0019-.0028, I have a feeling they didn't get as many as they hoped. Thanks to folks here on this board with top notch DD, many are holding and not falling for the tactics they use.
They will have to let it lose soon, the buying pressure will be to much.
I don't want to say crazy PPS numbers right now, but I wouldn't be surprised if it went beyond the numbers I think.
I have a list of pennies that trade at this range.
Keeping my eye on this one...
IMO that won't happen, but a fact is Audit 2 will on the 16th.
100% chance that nobody on this board knows if they will or wont.
Yeah, thats after the Audit and CE mark & M/A.
12 days away....
Maybe I should have added that I was referring to a steady climb from the bottom, which was at .002.
No red mean stop, green mean go and yellow me slow dooowwwnnn
12 days (10 trading days) left. Steady climb up is good with me!
Audits themselves typically take 1 to 2 days for Stage 1 and 1-1/2 days to 5 days or more for stage 2 depending on the size of the facility and the number of sites.
Since the Audit falls on a friday, I am assuming this could possibly be done in one day, but thats my opinion.
@)-;-WHY SNDY IS BUZZING-;-(@
SNDY has completed Audit (stage 1) with TÜV 2/26/13
SNDY is days away from its final Audit (stage 2) with TÜV 8/16/13
Expert resources will attend the final Audit to make sure all goes as planned.
-Most recent news -SNDY has Emergo Group as their European Authorized Representative
(final step before notified body TÜV conducts Audit)
Once the successful results of this final Audit is released, SNDY will be FDA + ISO 13485 + CE Mark approved.
2-8 weeks for paperwork and to receive certificates.
At this stage they apply the CE MARK to their devices and products, and distribute them to canadian, european, US markets.
According to this research paper
Impact of the CE mark approval on exit opportunities and valuation for early stage medical device companies
-GREAT POSTS-
lol okay, But I would think several would fit the annual follow up Audit
Several = Being of a number more than two or three but not many
Few = anything that is more than one, but small in number.
Why choose Emergo Group as your European Authorized Representative?
*We are one of the largest Authorized Representatives for medical devices and IVDs, representing hundreds of medical device companies worldwide.
*We are a well-established business founded in 1997.
Our familiarity with the European regulatory environment and Competent Authorities allows us to promote the best interests of our clients.
*We are an ISO registered firm which includes European Authorized Representation in the scope of our registration.
You will receive free updates on European regulations for medical devices.
*You will have secure online access to all of your documentation including Technical Files, Labeling Information and Symbols, Language Requirements, Directives, Guidelines, and more.
*We maintain offices throughout Europe, Asia, Australia, North and South America so we can serve you efficiently regardless of your time zone.
What is the role of an EU Authorized Representative?
*Registers your devices with the national Competent Authorities before they are marketed, where applicable.
Acts as your primary contact point for all national Competent Authorities.
*Maintains a current copy of your Technical File available for inspection by the European Competent Authorities.
*Gives you authorization to place our name and address on your device labels, packaging and Instructions for Use.
*Always available to interact between you and the national Competent Authorities.
*Responsible for Incident and Field Safety Corrective Action (FSCA) reporting to Competent Authorities, in cooperation with you and your distributors.
*Protects the confidentiality of your documentation. The European Authorized Representative can only show technical documentation to Competent Authorities as required by law.
*Represents you to the European Commission for consultation in case of withdrawal of a medical device by a Member State(s).
*Maintains reports concerning the critical evaluation of all data collected during clinical evaluations for review by Competent Authorities.
*Notifies or is notified by the Competent Authorities of serious device incidents or FSCA.
- See more at: http://www.emergogroup.com/services/europe/european-authorized-representative#sthash.Or6JC33g.dpuf
I'm glad this baby has a AUDIT stage 2 date in 13 days.
IMO SNDY is doing what needs to be done in moderation with the AS. But really it won't matter to those who hold, M/A is what 95% of FDA & CE approved medical device companies go.
PR CAMPAIGN HAS BEGUN, WAITING ON THE BIG NEWS.
Im glad Im holding my position. ITS LOOKING MIGHTY GREEN!
Not worried, I'm more concerned with results leading to green light to go international. What's it at? 13 days? geez time flies!
Thats AS post #1 for the day!
AUDIT#2 = ISO 13485 = CE MARK = M/A (95% exit this way)
They are 13 days away from a successful Audit.
Theres nothing to delay the domino effect after a successful Audit. Its said and done. They are given a green light for CE Mark after Audit #2.
Obtaining Emergo Group to act as the Company's authorized representative in Europe is a good sign that CE mark will be awarded. This means after three years of waiting, SNDY will have the green light to go international. Their competitors will see this, especially the ones who control most of the market in EUROPE and CANADA. This will be confirmed in 13 DAYS with successful audit stage 2.
Like pennylanepam posted earlier, Emergo group is huge news.
No not yet, the only thing I found is this....
SOLOS ENDOSCOPY (SNDY) SURGES 80% AS JOINT VENTURE TALKS WITH OLEA MEDICAL HAPPEN IN CAMBRIDGE, MASSACHUSETTS VENTURES SIERRA WORLD EQUITY REVIEW
http://www.sierraworldequityreview.com/2013/07/19/solos-endoscopy-sndy-surges-80-as-joint-venture-talks-with-olea-medical-happen-in-cambridge-massachusetts-ventures-sierra-world-equity-review/
This is a rumor I understand, but it would be nice to know if there is any truth behind this.....
Have you found any information as to Olea Medical?
I received a response...
Emergo Group to act as the Company's authorized representative in Europe
THIS IS REQUIRED IN ORDER TO RECEIVE CE MARK
SOLOS ENDOSCOPY (SNDY) SURGES 80% AS JOINT VENTURE TALKS WITH OLEA MEDICAL HAPPEN IN CAMBRIDGE, MASSACHUSETTS VENTURES SIERRA WORLD EQUITY REVIEW
http://www.sierraworldequityreview.com/2013/07/19/solos-endoscopy-sndy-surges-80-as-joint-venture-talks-with-olea-medical-happen-in-cambridge-massachusetts-ventures-sierra-world-equity-review/
Still waiting on a reply, I assume he would respond in the same time frame....
Emergo Group corporate video
http://www.emergogroup.com/resources/videos-corporate-video
Thats great DD, it would be good to know details on such information!
Let us know what you find when they respond!
Nice close green! SNDY climbing back up!
PR CAMPAIGN has started, should end with a bang!
Huge 1,795,546 Buy at .0031
Nice!
I'm still looking for more information that can help shed some light to this. I'm sure many are as well!
Obviously not everybody, I think big money can see what's transparent and agenda driven. good luck with picking up at .0009 while the R/S on a R/S with the sky falling dilution palm reading.
LOL whats interesting is that its SNDY not SNYD...lol
LOL Solos is a R&D company, come on brother you already know this.
He is a consultant that was a founder when it was private. He can easily be rehired as a consultant that knows Solos better than any other person that would, just for the purpose acquisition, help SNDY management prepare for its final exit. Usually this kind of information is only released when the requirements are met in the contract. Requirements such as CE mark.
In the history of bard medical, nowhere does it say they acquired anything from Solos Endoscopy. 100 years of history not one shred of anything linking the two.
Another point would be why would he put something that was done over 20 years ago on a bio? You would think he had more recent and better things to put down if this was old.
Unless this executive consultant lied on his bios on this website, I would only assume this is recent and true.
A friend of Robert Segersten (ceo)? Possibly...
I've pulled up every shred of information on the web about SNDY, and I never found this until about 2 weeks ago.
SEE SNDY MOVE UP - SLOW AND STEADY - AS EXPECTED BY MANY
until 8/16/13 when stage 2 is succesfully completed and PR of M/A.
THEN KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!
Who will acquire Solos Endoscopy?
Bard Medical?
Executive consultant has the words "prepared Solos for acquisition with Bard Medical". This is very interesting, because there is no history of this happening, and it seems that this is recent, or I would have found it a long time ago and it was updated in may. Bard medical sold their endoscopy business for 80m, leaving this big medical device company with limited devices in that area.
http://www.agileedgetech.com/whoweare/executive_bios.php
Acquisition with Bard Medical makes sense...
Quote:
COMPANY NEWS; CONMED TO BUY BARD'S ENDOSCOPIC UNIT FOR $80 MILLION
Published: August 19, 2004
SIGN IN TO E-MAIL
PRINT
The ConMed Corporation, a maker of surgical instruments, said yesterday that it would buy the endoscopic unit of C.R. Bard Inc. for $80 million, gaining products used to treat diseases of the digestive tract. Bard's endoscopic business, with sales of about $54 million last year, is based in Billerica, Mass., and employs about 200 workers, the companies said. ConMed, which specializes in medical instruments for sports medicine and had sales of $497.1 million last year, said the purchase would add about 12 cents a share to next year's earnings, before certain costs. ConMed, based in Utica, N.Y., said it would leave the endoscopic business mostly intact
http://www.bardmedical.com/About
We also can see that Bard is focused on building a larger catalog for a growing demand in early breast cancer detection devices.
Quote:
C. R. Bard Acquires Breast Cancer Device Company for Approximately $213 Million
July 6, 2010
July 6, 2010 – C. R. Bard Inc. announced today that it has completed its acquisition of SenoRx Inc., a manufacturer of breast cancer treatment devices. Under the terms of the merger agreement, SenoRx stockholders will receive $11 in cash for each share held of SenoRx common stock, a premium of approximately 14 percent over the closing price of SenoRx shares on May 4, 2010, the last trading day before the public announcement of the acquisition.
With the closing of the transaction, trading in SenoRx common shares was suspended. SenoRx common shares ceased to trade on NASDAQ at market close July 6 and were delisted.
SenoRx develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor vacuum-assisted breast biopsy system and Contura MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx’s field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S.
http://www.itnonline.com/article/c-r-bard-acquires-breast-cancer-device-company
I wonder where those 6,000,000 shares went at EOD @ .0028. Somebody with big $$ obviously thinks SNDY will be huge
lol Many know what a pink about to go into a R/S looks and feels like. This is not one of them. Can you name one that has FDA & is about to receive CE mark to R/S? yeah I thought so. SNDY IS A CHAMP
This has ACQUISITION written all over it.
Glad I loaded up!